Treatment of Oral Thrush
For mild oral thrush, start with clotrimazole troches 10 mg five times daily for 7-14 days, but for moderate to severe disease, use oral fluconazole 100-200 mg daily for 7-14 days, which is the gold standard with superior efficacy. 1, 2
Treatment Algorithm Based on Disease Severity
Mild Disease (First-Line Options)
- Clotrimazole troches 10 mg five times daily for 7-14 days is the preferred first-line therapy with strong recommendation and high-quality evidence 1, 2
- Miconazole mucoadhesive buccal tablet 50 mg once daily for 7-14 days applied to the mucosal surface over the canine fossa offers more convenient once-daily dosing 1, 2
- Nystatin suspension 4-6 mL (100,000 U/mL) four times daily for 7-14 days is an alternative, though it has lower efficacy (32-54% cure rates) and requires swishing in the mouth as long as possible before swallowing 1, 3, 4
- Nystatin pastilles 1-2 tablets (200,000 U each) four times daily for 7-14 days can also be used 1, 3
Moderate to Severe Disease (First-Line)
- Oral fluconazole 100-200 mg daily for 7-14 days is strongly recommended with high-quality evidence and demonstrates 100% clinical cure rates compared to nystatin's 32-54% 1, 2, 3, 4
- This is the gold standard for moderate to severe disease and should be prioritized over topical agents 2, 3
Fluconazole-Refractory Disease
When fluconazole fails, escalate systematically:
- Itraconazole solution 200 mg once daily for up to 28 days (effective in approximately two-thirds of fluconazole-refractory cases) 1, 2, 5
- Posaconazole suspension 400 mg twice daily for 3 days, then 400 mg daily for up to 28 days 1, 2
- Voriconazole 200 mg twice daily 1, 2
- Amphotericin B deoxycholate oral suspension 100 mg/mL four times daily 1, 2
- For severe refractory disease, intravenous echinocandins (caspofungin 70 mg loading dose then 50 mg daily, micafungin 100 mg daily, or anidulafungin 200 mg loading dose then 100 mg daily) 1, 2
Patients Unable to Tolerate Oral Therapy
- Intravenous fluconazole 400 mg (6 mg/kg) daily is the preferred option 1, 2
- Intravenous echinocandins (micafungin 150 mg daily, caspofungin 70 mg loading then 50 mg daily, or anidulafungin 200 mg daily) are equally effective alternatives 1, 2
- Intravenous amphotericin B deoxycholate 0.3 mg/kg daily is a less preferred alternative 1, 2
Special Populations and Considerations
Denture-Related Candidiasis
- Denture disinfection is mandatory in addition to antifungal therapy—remove dentures at night and clean thoroughly 1, 2, 3
- Without denture disinfection, antifungal therapy alone will fail 2
HIV-Infected Patients
- Antiretroviral therapy is strongly recommended to reduce recurrence rates, which is more important than the choice of antifungal 1, 2, 3
- May require longer treatment courses or higher doses of antifungal medications 2
- For chronic suppression if recurrent infections occur: fluconazole 100 mg three times weekly 1, 2, 3
Recurrent Infections
- Chronic suppressive therapy is usually unnecessary 1
- If required: fluconazole 100 mg three times weekly with strong recommendation and high-quality evidence 1, 2, 3
Common Pitfalls and Caveats
Avoid using nystatin for moderate to severe disease or immunocompromised patients—it has suboptimal tolerability and significantly lower efficacy compared to fluconazole 3
Do not use topical agents alone for esophageal involvement—systemic therapy is always required if esophageal candidiasis is suspected 1, 3
Continue treatment for at least 48 hours after symptoms disappear and cultures confirm eradication to prevent recurrence 3
Assess for drug interactions with miconazole before prescribing, as it can interact with other medications 6
Be aware of emerging fluconazole resistance, particularly in high-risk patients with AIDS—early aggressive management and consideration of alternative agents is critical 7